Cardiovascular Systems, Inc. CSII recently announced an acquisition option agreement with Chansu Vascular Technologies, LLC (CVT) for the development of a peripheral everolimus drug-coated balloon ...
With the help of a small California startup, Cardiovascular Systems has laid out plans to build a full portfolio of minimally invasive medical hardware designed to remove blood clots. The devicemaker ...
The endothelial glycocalyx integrates mechanical signals with vascular biology, playing a vital role in health and disease, ...
Historically, much of the research conducted in our 'Heart Lab' has been at the interface of medicine and engineering, dedicated to the discovery and development of innovative methodologies (molecular ...
TYLER, Texas--(BUSINESS WIRE)-- NanoVibronix, Inc. (NAOV) (“NanoVibronix” or the “Company”), a medical technology company specializing in non-invasive therapeutic systems, today announced the official ...
Cellular biomechanics of neural and vascular injury, mechanotransduction in the cardiovascular system, mechanical control of growth and development for wound healing and tissue engineering Engineering ...
ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI ®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients ...
The field of tumor microenvironment research has increasingly highlighted the intertwined relationship between aberrant vasculature and dysregulated immune ...
Coronary arteries are a vital part of the human heart, providing it with oxygen-rich blood so that it can work. By comparing the hearts of mammals, birds, reptiles, fish and frogs, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results